Pharmaprojects

The industry standard for tracking and analyzing the global drug R&D landscape

Citeline's Pharmaprojects has been monitoring and analyzing global pharma R&D activity and trends across diseases, drugs, companies and more for over 40 years. With 90,000+ drug profiles, including 20,000 drugs in active development, Pharmaprojects is the trusted reference for the global drug R&D industry pipeline, providing a holistic view from preclinical to launch.

Unlock a New Era of Insight with Pharmaprojects⁺

Pharmaprojects⁺ enhances the trusted pipeline data of Pharmaprojects with new tools for faster, data-backed decisions.

Users can identify similar drugs using the Drug Similarity tool — supporting competitive analysis and asset evaluation. Advanced Analytics reveals historical development trends by drug type, target, and company to guide strategy.

With Company Compare, users can benchmark pipelines by disease, maturity, and activity. Ella, the AI chat assistant, helps create and validate search strategies in seconds.

From tracking the competitive landscape to shaping smarter strategies, Pharmaprojects⁺ helps users move with greater speed and confidence.

What's included:

		Pharmaprojects	Pharmaprojects⁺
Home		✓	✓
Query		✓	✓
Analytics	Trends	✓	✓
	Landscape Analysis	✓	✓
	Company Compare	–	✓
Drug Similarity		–	✓
Ella, AI Chat Assistant		–	✓

The drug development landscape mapped for you

Clinical R&D has exploded in recent years with an ever-increasing number of drugs moving through the pipeline. Keeping track of developments is an almost insurmountable task due to the number of sources, and filtering through it all is extraordinarily frustrating.

But with an extensive team of therapeutically aligned expert analysts building upon and curating a database that is already recognized as the absolute gold standard, we can remove that frustration and enable you to develop the insights that will successfully move your organization forward.

Healthcare professional monitoring and analyzing R and D trends.

How it helps

Identify fallen angels for in-licensing or partnership opportunities
Conduct due diligence on existing drug opportunities
Actively monitor the competitive development landscape
Keep tabs on historic or emerging development trends

Take in high-level landscape at details by utilizing a flexible results table or build personalized, customizable dashboards to review the data visually.

How it works

Our best-in-class database, combined with our extensive set of filters, means you can craft a landscape based the criteria that matter to you.

Never lose track of developments with a flexible alerting feature, and save searches for future reference.

What's included

Support business development, licensing and outreach activities

Target new assets, conducting due diligence and identifying relevant sponsors using Pharmaprojects’ intuitive interface. Get laser focused on the data that matters most to you, by using an extensive range of filters to interrogate our best-in-class and extensively indexed database.

Assess the competitive landscape

Build a picture of all potentially competing drugs across a range of criteria and never lose track of developments by employing built-in alerting functionality. Create reports combining insights from across Pharmaprojects and Trialtrove to paint complete picture of when assets may come online and impact your own strategy.

Monitor vital market trends

Whether you’re tracking drug launches across therapeutic areas, orphan drug status designations or discontinuations, Pharmaprojects gets you to the information you need quickly and easily.

Get direct access to our leading expert analysts

Our Ask-The-Analyst^TM service is second to none. Subscribers go straight to the source with a direct, unlimited link to our therapeutically aligned expert analysts.

Our experts

Our data is curated by the industry’s largest team of therapeutically aligned, expert analysts, making Citeline the most trusted source of R&D intelligence on the market.

Our analysis, insight and consultancy services span drug, device, company, clinical trial and market intelligence. And because our approach is interconnected, our analysts can give a broader perspective, identifying disruptive events, and in turn, helping you spot opportunities and mitigate risk.

No other company can boast our level of expertise and we are proud to be able to pass on the benefits of the approach we take to data collection, curation and analysis to our customers.